Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d'Ivoire: A prospective cohort study

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Mounkaila Harouna, Aïda ^a,b   Amorissani Folquet, Madeleine ^c   Eboua, François Tanoh ^d   Desmonde, Sophie ^a,b,am   N'Gbeche, Marie Sylvie ^e,l   Aka, Edmond Addi ^e,l   Kouadio, Kouakou ^f   Kouacou, Brou ^g   Malateste, Karen ^a,b,am   Bosse Amani, Clarisse ^g   Ahuatchi Coffie, Patrick ^c   Leroy, Valeriane ^a,b,am   Zannou, Djimon Marcel ^h   Ahouada, Carin ^h   Akakpo, Jocelyn ^h   Ahomadegbe, Christelle ^h   Bashi, Jules ^h   Gougounon Houeto, Alice ^h   Azon Kouanou, Angèle ^h   Houngbe, Fabien ^h   Sehonou, Jean ^h   Koumakpaï, Sikiratou ^h   Alihonou, Florence ^h   d'Almeida, Marcelline ^h   Hodonou, Irvine ^h   Hounhoui, Ghislaine ^h   Sagbo, Gracien ^h   Tossa Bagnan, Leïla ^h   Adjide, Herman ^h   Drabo, Joseph ⁱ   Bognounou, Rene ⁱ   Diendere, Arnaud ⁱ   Traore, Eliezer ⁱ   Zoungrana, Lassane ⁱ   Zerbo, Beatrice ⁱ   Sawadogo, Adrien Bruno ^j   Zoungrana, Jacques ^j   Hema, Arsène ^j   Sore, Ibrahim ^j   Bado, Guillaume ^j   Tapsoba, Achille ^j   Ye, Diarra ^k   Koueta, Fla ^k   Ouedraogo, Sylvie ^k   Ouedraogo, Rasmata ^k   Hiembo, William ^k   Gansonre, Mady ^k   Messou, Eugène ^l   Gnokoro, Joachim Charles ^l   Kone, Mamadou ^l   Kouakou, Guillaume Martial ^l   Bosse, Clarisse Amani ^m   Brou, Kouakou ^m   Assi, Achi Isidore ^m   Chenal, Henri ⁿ   Hawerlander, Denise ⁿ   Soppi, Franck ⁿ   Minga, Albert ^o   Abo, Yao ^o   Yoboue, Jean Michel ^o   Eholie, Serge Paul ^p   Amego, Mensah Deborah Noelly ^p   Andavi, Viviane ^p   Diallo, Zelica ^p   Ello, Frederic ^p   Tanon, Aristophane Koffi ^p   Koule, Serge Olivier ^p   Anzan, Koffi Charles ^q   Guehi, Calixte ^q   Issouf, Koffi Ladji ^l   Kouakou, Jean Claude ^l   Pety, Toure ^m   Avit Edi, Divine ^m   Kouakou, Kouadio ⁿ   Moh, Magloire ⁿ   Yao, Valerie Andoble ⁿ   Folquet, Madeleine Amorissani ^q   Dainguy, Marie Evelyne ^q   Kouakou, Cyrille ^q   Mea Assande, Veronique Tanoh ^q   Oka Berete, Gladys ^q   Zobo, Nathalie ^q   Acquah, Patrick ^q   Kokora, Marie Berthe ^q   Eboua, Tanoh François ^r   Timite Konan, Marguerite ^r   Ahoussou, Lucrèce Diecket ^r   Assouan, Julie Kebe ^r   Sami, Mabea Flora ^r   Kouadio, Clemence ^r   Renner, Lorna ^s   Goka, Bamenla ^t   Welbeck, Jennifer ^t   Sackey, Adziri ^t   Owiafe, Seth Ntiri ^t   Wejse, Christian ^t   Da Silva, Zacarias Jose ^t   Paulo, Joao ^t   Rodrigues, Amabelia ^u   da SilvaD , David ^v   Medina, Candida ^w   Oliviera Souto, Ines ^u   Østergaard, Lars ^x   Laursen, Alex ^x   Sodemann, Morten ^y   Aaby, Peter ^u   Fomsgaard, Anders ^z   Erikstrup, Christian ^aa   Eugen Olsen, Jesper ^aa   Leuenberger, David ^ab   Hebelamou, Jean ^ab   Maïga, Moussa Y ^ac   Diakite, Fatoumata Fofana ^ac   Kalle, Abdoulaye ^ac   Katile, Drissa ^ac   Traore, Hamar Alassane ^ad   Minta, Daouda ^ad   Cisse, Tidiani ^ad   Dembele, Mamadou ^ad   Doumbia, Mohammed ^ad   Fomba, Mahamadou ^ad   Kaya, Assetou Soukho ^ad   Traore, Abdoulaye M ^ad   Traore, Hamady ^ad   Toure, Amadou Abathina ^ad   Dicko, Fatoumata ^ac   Sylla, Mariam ^ac   Berthe, Alima ^ac   Traore, Hadizatou Coulibaly ^ac   Koita, Anta ^ac   Kone, Niaboula ^ac   N'Diaye, Clementine ^ac   Coulibaly, Safiatou Toure ^ac   Traore, Mamadou ^ac   Traore, Naïchata ^ac   Charurat, Man ^ae   Kwaghe, Vivian ^af   Ajayi, Samuel ^af   Alim, Georgina ^af   Dapiap, Stephen ^af   Otu, ^af   Igbinoba, Festus ^ag   Benson, Okwara ^ah   Adebamowo, Clement ^ah   James, Jesse ^ah   Obaseki, ^ah   Osakede, Philip ^ah   Olasode, John ^ai   Seydi, Moussa ^aj   Sow, Papa Salif ^aj   Diop, Bernard ^aj   Manga, Noël Magloire ^aj   Tine, Judicael Malick ^aj   Bassabi, Coumba Cisse ^aj   Sy, Haby Signate ^ak   Ba, Abou ^ak   Diagne, Aida ^ak   Dior, Helène ^ak   Faye, Malick ^ak   Gueye, Ramatoulaye Diagne ^ak   Mbaye, Aminata Diack ^ak   Patassi, Akessiwe ^al   Kotosso, Awèrou ^al   Kariyare, Benjamin Goilibe ^al   Gbadamassi, Gafarou ^al   Komi, Agbo ^al   Mensah Zukong, Kankoe Edem ^al   Pakpame, Pinuwe ^al   Lawson Evi, Koko ^al   Atakouma, Yawo ^al   Takassi, Elom ^al   Djeha, Ameyo ^al   Ephoevi gah, Ayoko ^al   Djibril, Sherifa El Hadj ^al   Dabis, François ^am   Bissagnene, Emmanuel ^am   Arrive, Elise ^am   Coffie, Patrick ^am   Ekouevi, Didier ^am   Jaquet, Antoine ^am   Lewden, Charlotte ^am   Sasco, Annie J ^am   Azani, Jean Claude ^am   Balestre, Eric ^am   Bessekon, Serge ^am   Karcher, Sophie ^am   Gonsan, Jules Mahan ^am   Le Carrou, Jerôme ^am   Lenaud, Severin ^am   Nchot, Celestin ^am   Yao, Amon Roseamonde ^am   Cisse, Abdoulaye ^am   Doring, Alexandra ^am   Kouakou, Adrienne ^am   Gneppa, Guy ^am   Rabourdin, Elodie ^am   Rivenc, Jean ^am   Anglaret, Xavier ^am   Ba, Boubacar ^am   Becquet, Renaud ^am   Soto, Juan Burgos ^am   Essanin, Jean Bosco ^am   Ciaranello, Andrea ^am   Datte, Sebastien ^am   Elvis Diby, Jean Serge ^am   Gottlieb, Geoffrey S ^am   Horo, Apollinaire Gninlgninrin ^am   Jesson, Julie ^am   N'zore Kangah, Serge ^am   Meless, David ^am   Mounkaila Harouna, Aida ^am   Ndondoki, Camille ^am   Shiboski, Caroline ^am   Tchounga, Boris ^am   Thiebaut, Rodolphe ^am   Wandeler, Gilles ^am   more..

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

^d University Hospital of Yopougon   (Côte d’Ivoire)

^e ACONDA   (Côte d’Ivoire)

^f CIRBA   (Côte d’Ivoire)

^g MTCT Plus Programme   (Côte d’Ivoire)

^h CNHU Hubert K Maga   (Benin)

ⁱ Service d'Urologie   (Burkina Faso)

^j CHU Souro Sanou   (Burkina Faso)

^k Charles De Gaulle Pediatric University Teaching Hospital   (Burkina Faso)

^l ACONDACePReF   (Côte d’Ivoire)

^m ACONDA MTCT Plus   (Côte d’Ivoire)

ⁿ CIRBA   (United States)

^o CMSDS CNTS   (Côte d’Ivoire)

^p CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^q CHU de Cocody   (Côte d’Ivoire)

^r CHU Yopougon   (Côte d’Ivoire)

^s Korle Bu TH   (Ghana)

^t Bandim Health Amabelia Rodrigues   (Guinea-Bissau)

^u BANDIM HEALTH PROJECT   (Guinea-Bissau)

^v National HIV Program Bissau   (Guinea-Bissau)

^w Simão Mendes National Hospital   (Guinea-Bissau)

^x AARHUS UNIVERSITY HOSPITAL   (Denmark)

^y ODENSE UNIVERSITY HOSPITAL   (Denmark)

^z STATENS SERUM INSTITUT   (Denmark)

^aa HVIDOVRE HOSPITAL   (Denmark)

^ab Centre Medical Macenta   (Switzerland)

^ac CH Gabriel Toure   (Switzerland)

^ad CH Point G   (Canada)

^ae UMB IHV   (United States)

^af UATH   (Nigeria)

^ag NATIONAL HOSPITAL   (Nigeria)

^ah UBTH   (Nigeria)

^ai OATH Ile Ife   (Nigeria)

^aj SMIT CHU Fann   (Senegal)

^ak CH Albert Royer   (Canada)

^al CHU Tokoin Sylvanus Olympio   (Togo)

^am Département de Dermatologie et d'Infectiologie ^*  (Senegal)

more..

Author keywords

Africa; Antiretroviral therapy; Children; Cotrimoxazole; HIV; Malaria

Indexed keywords

COTRIMOXAZOLE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIMALARIAL AGENT;

AFRICA; ARTICLE; BLOOD SMEAR; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INCIDENCE RATIO RATE; MAJOR CLINICAL STUDY; MALARIA; MALE; POISSON DISTRIBUTION; PROSPECTIVE STUDY; RAINY SEASON; RETROSPECTIVE STUDY; SEASONAL VARIATION; COMPLICATION; COTE D'IVOIRE; HIV INFECTIONS; PRESCHOOL CHILD; REGRESSION ANALYSIS;

ANTI-HIV AGENTS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COTE D'IVOIRE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INCIDENCE; MALARIA; MALE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION;

EID: 84938685986     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-1009-6     Document Type: Article

References (38)

1. World Health Organization (WHO). World malaria report 2011. Geneva: WHO; 2011.
2. World Health Organization (WHO), Joint United Nations programme on HIV/AIDS (UNAIDS), United Nations Children's Fund (UNICEF). Global HIV/AIDS response. Epidemic update and health sector progress towards Universal Access. Geneva: UNAIDS; 2011.
3. World Health Organization (WHO). Malaria and HIV interactions and their implications for public health policy. Report of a Technical Consultation. Geneva: WHO; 2004.
4. World Health Organization (WHO). WHO/AFRO welcomes preliminary results of malaria vaccine trials. La toile, WHO/AFRO Malaria Newsletter. 2011;3(2):4. http://www.afro.who.int/fr/groupes-organiques-etprogrammes/ddc/paludisme/mal-publications.html . Accessed 23 apr 2012.
5. Ezeamama AE, Spiegelman D, Hertzmark E, Bosch RJ, Manji KP, Duggan C, et al. HIV Infection and the Incidence of Malaria Among HIV-Exposed Children from Tanzania. The Journal of Infectious Diseases. 2012. http://www.ncbi.nlm.nih.gov/pubmed/22457274 . Accessed 15 apr 2012.
6. Anglaret X, Chêne G, Attia A, Toure S, Lafont S, Combe P, et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial: Cotrimo-CI Study Group. Lancet. 1999;353(9163):1463-8.
7. Walker AS, Mulenga V, Ford D, Kabamba D, Sinyinza F, Kankasa C, et al. The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children. Clin Infect Dis. 2007;44(10):1361-7.
8. Kyeyune FX, Calis JCJ, Phiri KS, Faragher B, Kachala D, Brabin BJ, et al. The interaction between malaria and human immunodeficiency virus infection in severely anaemic Malawian children: a prospective longitudinal study. Trop Med Int Health. 2014;19(6):698-705.
9. Laufer MK, Van Oosterhout JJG, Thesing PC, Thumba F, Zijlstra EE, Graham SM, et al. Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi. J Infect Dis. 2006;193(6):872-8.
10. Bronzan RN, Taylor TE, Mwenechanya J, Tembo M, Kayira K, Bwanaisa L, et al. Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome. J Infect Dis. 2007;195(6):895-904.
11. Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza F, Lishimpi K, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet. 2004;364(9448):1865-71.
12. Ministère de la Santé et de la Lutte contre le SIDA. Annuaire des statistiques. Abidjan: Ministère de la Santé et de la Lutte contre le SIDA; 2012.
13. Organisation mondiale de la Santé. Données de l'Observatoire mondial de la santé. Situation sanitaire du pays. OMS; 2011. http://www.who.int/countries/civ/fr/ . Accessed 3 June 2012.
14. Ekouevi DK, Azondekon A, Dicko F, Malateste K, Touré P, Eboua FT, et al. 12-month mortality and loss-to-program in antiretroviral-treated children: The IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008. BMC Public Health. 2011;11:519.
15. Organisation mondiale de la Santé (OMS). Directives pour le traitement du paludisme. 2eth ed. Genève: OMS; 2011.
16. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000;94, Supplement 1(0):1-90.
17. Organisation mondiale de la Santé (OMS), Département des Maladies transmissibles- Surveillance et Action. Normes recommandées par l'OMS pour la Surveillance. 2eth ed. Genève: OMS; 2000.
18. Desenclos JC, Dabis F. Epidémiologie de terrain, Méthodes et applications. Paris: John Libbey Eurotext; 2012.
19. World Health Organisation (WHO). Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. Revision 2010. Geneva: WHO; 2010.
20. Desmonde S, Coffie P, Aka E, Amani-Bosse C, Messou E, Dabis F, et al. Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009. BMC Infect Dis. 2011;11:182.
21. Gasasira AF, Kamya MR, Ochong EO, Vora N, Achan J, Charlebois E, et al. Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance. Malar J. 2010;9:177.
22. Kamya MR, Gasasira AF, Achan J, Mebrahtu T, Ruel T, Kekitiinwa A, et al. Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children. AIDS. 2007;21(15):2059-66.
23. Campbell JD, Moore D, Degerman R, Kaharuza F, Were W, Muramuzi E, et al. HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea. Clin Infect Dis. 2012;54(8):1204-11.
24. Manyando C, Njunju EM, D'Alessandro U, Van Geertruyden J-P. Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review. PLoS One. 2013;8(2), e56916.
25. Murray CJL, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):1005-70.
26. Mbeye NM, Ter Kuile FO, Davies M-A, Phiri KS, Egger M, Wandeler G, et al. Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health. 2014;19(9):1057-67.
27. Mermin J, Ekwaru JP, Liechty CA, Were W, Downing R, Ransom R, et al. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet. 2006;367(9518):1256-61.
28. Greenhalgh S, Ndeffo M, Galvani AP, Parikh S. The epidemiological impact of HIV antiretroviral therapy on malaria in children. AIDS. 2015;29(4):473-82.
29. Parikh S, Gut J, Istvan E, Goldberg DE, Havlir DV, Rosenthal PJ. Antimalarial Activity of Human Immunodeficiency Virus Type 1 Protease Inhibitors. Antimicrob Agents Chemother. 2005;49(7):2983-5.
30. Skinner-Adams TS, McCarthy JS, Gardiner DL, Hilton PM, Andrews KT. Antiretrovirals as antimalarial agents. J Infect Dis. 2004;190(11):1998-2000.
31. ART regimen protects children from malaria. BMJ. 2012;345:e8214. http://www.ncbi.nlm.nih.gov/pubmed/23207506 . Accessed 26 july 2013.
32. Achan J, Kakuru A, Ikilezi G, Ruel T, Clark TD, Nsanzabana C, et al. Antiretroviral Agents and Prevention of Malaria in HIV-Infected Ugandan Children. N Engl J Med. 2012;367(22):2110-8.
33. Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H, et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet. 2000;356(9235):1051-6.
34. Olusegun Akinbo F, Omoregie R. Plasmodium falciparum infection in HIV-infected patients on highly active antiretroviral therapy (HAART) in Benin City. Nigeria J Res Health Sci Winter-Spring. 2012;12(1):15-8.
35. Initiative développement (ID), Sidaction. Guide de prise en charge de l'infection par le VIH chez l'enfant. Manuel pour les personnels impliqués dans la prise en charge pédiatrique du VIH. Paris: Grandir; 2010.
36. World Health Organisation (WHO). Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a public health approach. Geneva: WHO, UNAIDS; 2013. http://www.who.int/hiv/pub/guidelines/arv2013/download/en/index.html . Accessed 30 June 2013.
37. Akachi Y, Atun R. Effect of investment in malaria control on child mortality in sub-Saharan Africa in 2002-2008. PLoS One. 2011;6(6), e21309.
38. United Nations Millennium Development Goals. http://www.un.org/millenniumgoals/aids.shtml . Accessed 26 jul 2013.